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Abstract (229 words) 25 
Repression of the cellular CIITA gene is part of the immune evasion strategy of 26 
the herpes virus Epstein-Barr virus (EBV) during its lytic replication cycle in B-27 
cells. In part this is mediated through down regulation of MHC class II gene 28 
expression via the targeted repression of CIITA, the cellular master regulator of 29 
MHC class II gene expression. The repression is achieved through a reduction in 30 
CIITA promoter activity initiated by the EBV transcription and replication factor 31 
Zta (BZLF1, EB1, ZEBRA). Zta is the earliest gene expressed during the lytic 32 
replication cycle. Zta interacts with sequence specific elements in promoters, 33 
enhancers and the replication origin (ZREs) and also modulates gene expression 34 
through interaction with cellular transcription factors and co-activators. Here we 35 
explore the requirements for Zta-mediated repression of the CIITA promoter. We 36 
find that repression by Zta is specific for the CIITA promoter and can be achieved 37 
in the absence of other EBV genes. Surprisingly, we find that the dimerization 38 
region of Zta is not required to mediate repression. This contrasts with an 39 
obligate requirement of this region to correctly orientate the DNA contact 40 
regions of Zta to mediate activation of gene expression through ZREs. Additional 41 
support for the model that Zta represses the CIITA promoter without direct DNA 42 
binding comes from promoter mapping that shows that repression does not 43 
require the presence of a ZRE in the CIITA promoter. 44 
 45 
Introduction 46 
Epstein–Barr virus infects people and has a life-long association with them, 47 
occasionally causing diseases including infectious mononucleosis, Burkitt’s 48 
lymphoma, Hodgkin’s lymphoma and Nasopharygeal carcinoma (Magrath, 2012; 49 
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Molyneux et al., 2012; Saha & Robertson, 2011). Epstein–Barr virus infects 50 
human B-lymphocytes and epithelial cells and establishes long-term latency in 51 
memory B-lymphocytes (Babcock et al., 1998). These cells are largely protected 52 
from immune attack by the silencing of viral gene expression. The virus is 53 
sporadically reactivated following B-cell activation and differentiation into 54 
plasma cells (Crawford & Ando, 1986; Laichalk et al., 2002; Laichalk & Thorley-55 
Lawson, 2005). As EBV enters the lytic replication cycle, it expresses around 90 56 
viral genes that are required for the regulation of viral gene expression, 57 
replication of the viral genome, assembly, packaging, and egress of the virion 58 
(Farrell, 2005). Many viral genes expressed during viral lytic replication are 59 
excellent targets for immune recognition (Adhikary et al., 2006; Long et al., 60 
2011). Attack by the immune system during viral replication would threaten cell 61 
survival and thus the successful generation of virions, but EBV has evolved 62 
several strategies to evade immune responses during viral lytic replication (Zuo 63 
& Rowe, 2012).  64 
 65 
An important regulator of EBV lytic replication termed Zta (BZLF1, ZEBRA, EB1) 66 
is a transcription factor, a replication factor and it disrupts several signal 67 
transduction pathways (Kenney, 2007). Routes by which Zta activates gene 68 
expression has been documented for both viral and host promoters.  Many 69 
promoters are targeted by the interaction of the sequence-specific DNA binding 70 
domain of Zta with sequence specific 7-nucleotide DNA elements termed ZREs 71 
(for example (Adamson & Kenney, 1999; Bergbauer et al., 2010; Bhende et al., 72 
2004; 2005; Broderick et al., 2009; Dickerson et al., 2009; Flower et al., 2011; 73 
Holley-Guthrie et al., 1990; Kalla et al., 2012; Kalla et al., 2010; Karlsson et al., 74 
Downloaded from www.microbiologyresearch.org by
IP:  139.184.66.134
On: Wed, 17 Feb 2016 13:46:44
 4 
2008; Kenney et al., 1989; Ramasubramanyan et al., 2012a; Ramasubramanyan 75 
et al., 2012b; Sinclair, 2003; Sinclair et al., 1991; Woellmer et al., 2012). At least 76 
32 distinct ZRE sequence variants are specifically recognized by Zta (Flower et 77 
al., 2011).  78 
 79 
Down regulation of gene expression by Zta has been documented for the TNFR1 80 
gene, through the cellular C/EBP genes (Bristol et al., 2010). Additionally, post-81 
translational modifications of Zta have been shown to reduce the ability of Zta to 82 
regulate gene expression, specifically phosphorylation at residue S209 (Asai et 83 
al., 2009) and sumoylation through residue K12 (Hagemeier et al., 2010; Murata 84 
et al., 2010).  85 
 86 
Zta has been shown to down regulate the expression of the master regulator of 87 
MHC class II gene expression, CIITA, in an EBV-positive B-cell line, with both 88 
protein and RNA levels decreasing following induction of EBV lytic cycle 89 
activation (Li et al., 2009). The product of CIITA is a non-DNA-binding cellular 90 
transcriptional co-activator, which acts through interaction with DNA-bound 91 
proteins that lack integral activation domains. CIITA activates the expression of 92 
MHC Class II genes (Chang et al., 2002) and the reduced expression of CIITA 93 
observed in B-cells undergoing lytic cycle correlates with the reduced expression 94 
of MHC class II observed at the cell surface (Li et al., 2009). Repression of CIITA 95 
gene expression is also driven by the related herpesvirus KSHV (Cai et al., 96 
2013). Here, we investigate the route by which Zta represses CIITA expression.    97 
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 98 
Results  99 
CIITA promoter is specifically repressed by the EBV Zta protein 100 
The effect of Zta expression on the activity of the CIITA promoter and the viral 101 
BHLF1 promoter were compared in EBV-positive Raji cells following co-102 
transfection of reporter constructs with an expression vector for a polyhistidine 103 
tagged version of Zta (Bailey et al., 2009). The impact of Zta expression was 104 
expressed relative to the maximal activity for each promoter (Fig. 1(a) and (b)). 105 
Expression of Zta repressed the CIITA promoter, whilst in the same experiment it 106 
dramatically activated expression of a viral promoter containing ZREs (BHLF1). 107 
This provides confirmation of the results of Li et al. showing that a short region 108 
of the CIITA promoter is sufficient to mediate repression following Zta 109 
expression (Li et al., 2009). The repression of CIITA promoter activity could 110 
result from the overexpression of a transactivator domain that non-specifically 111 
sequesters basal transcription factors or co-activators, thereby inhibiting all RNA 112 
polymerase II dependent transcription. To address whether this was the case, we 113 
undertook experiments to explicitly question whether Zta repressed other 114 
promoters. We generated promoter-reporter gene constructs for two viral 115 
promoters, BFLF2 and BLLF3. The impact of His-Zta expression on each 116 
promoter was assessed in Raji cells (Fig. 1 (c,d)). This showed that neither BLLF3 117 
nor BFLF2 promoters were repressed by Zta expression. We further investigated 118 
the repression of CIITA in BL cells by following two downstream targets of CIITA 119 
expression, HLA-DOA and HLA-DBM. Both are down regulated at the RNA level 120 
following Zta expression in BL cells (Supplementary Fig. 1).  121 
 122 
Downloaded from www.microbiologyresearch.org by
IP:  139.184.66.134
On: Wed, 17 Feb 2016 13:46:44
 6 
As Raji cells contain an EBV genome, changes in viral gene expression may occur 123 
as a consequence of activating a partial lytic replication cycle through the 124 
expression of Zta (Kallin & Klein, 1983). In order to question whether Zta relies 125 
on additional viral components to repress CIITA expression, we introduced the 126 
CIITA promoter-reporter gene into an EBV-negative sub-clone of Akata Burkitt’s 127 
lymphoma cells (AK31) (Jenkins et al., 2000). In this cell background we saw that 128 
co-expression of Zta drove repression of the CIITA promoter-reporter gene 129 
around 5-fold (Fig. 2). This clearly demonstrates that Zta-mediated repression of 130 
CIITA does not depend on additional EBV genes. 131 
 132 
To explore the relevance of post-translational modifications of Zta to the Zta-133 
mediated repression of the CIITA promoter, we generated mutants of Zta at 134 
amino acid residues K12 and S209 to prevent either sumoylation or 135 
phosphorylation. Following transfection we found that neither post-translational 136 
modification was required for Zta to repress the CIITA promoter (Table 1). 137 
 138 
Domains of Zta mediating repression of CIITA promoter 139 
We then explored which domains of Zta protein mediate the repression of CIITA. 140 
Two versions of Zta were generated; both of these retain the nuclear localization 141 
signal (Mikaelian et al., 1993). One mutant omits the N-terminal transactivation 142 
domain (ZtaTA), this protein was previously shown to be able to bind to DNA 143 
but not to transactivate a reporter construct (Packham et al., 1990). The second 144 
omits the dimerization and C-terminal region (ZtaH199ter) and has been shown 145 
previously to be unable to bind DNA (Hicks et al., 2003) or to form dimers 146 
(Schelcher et al., 2005) (Fig 3(a)). Following transfection into Raji cells we find 147 
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that deletion of the transactivation domain ablates the ability of Zta to repress 148 
the CIITA promoter, despite the proteins being expressed at an equivalent level 149 
(Fig. 3(b)). In contrast, deletion of the dimerization and C-terminal regions of Zta 150 
only resulted in a small reduction in the repression of the CIITA promoter (Fig. 151 
3(c)). The slightly lower level of repression observed with ZtaH199ter might 152 
result from the reduced abundance of this form of the protein. Taken together 153 
these data show that a major component of Zta mediated repression of the CIITA 154 
promoter occurs independently of a need for Zta to form dimers.  155 
 156 
It has been shown previously that a Zta binding site within the CIITA promoter 157 
allows repression by Zta (Li et al., 2009). Our data show that dimerization is not 158 
an obligate requirement for repression, implying that DNA binding is not 159 
required. To explore this further, we assessed the promoter for potential ZREs 160 
(Flower et al., 2011) and found only the one, which was shown to be a Zta 161 
binding site previously (Li et al., 2009). We confirm using Chromatin 162 
precipitation coupled to next generation DNA sequencing that Zta binds to the 163 
promoter region of CIITA (Supplementary Fig. 2), but note that this does not 164 
distinguish between direct and indirect binding. To evaluate the relevance of the 165 
potential ZRE, we generated a promoter reporter construct in which the region 166 
containing a ZRE was deleted (Fig. 4(a)). Both of these promoters are expressed 167 
at equivalent levels (Table 2). Both full length Zta and the dimerization-deficient 168 
mutant Zta-H199ter repressed the promoter missing the ZRE (Fig. 4(b)). This 169 
supports our contention that the ability of Zta to repress the expression of CIITA 170 
does not rely on direct DNA binding.  171 
 172 
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From these data we devised a model to account for Zta mediated activation and 173 
repression of gene expression. In cells expressing MHC class II, CIITA expression 174 
is driven by the interaction of cellular factors (RNA polymerase II and cellular co-175 
activators) (Fig. 5(a)). Once Zta is expressed it interferes with the activation 176 
machinery operating at the CIITA promoter, without the need to dimerize or 177 
bind to the promoter (Fig. 5(b)).  178 
 179 
Discussion 180 
The EBV protein Zta is often described as the master regulator of EBV lytic cycle 181 
replication. Indeed, the ability of Zta to regulate viral gene expression is crucial 182 
to the success of viral lytic replication, as mutation of the BZLF1 gene in 183 
recombinant EBV demonstrates (Feederle et al., 2000). The activation of viral 184 
gene expression is considered to occur through the interaction of Zta with 185 
sequence specific ZREs in the promoters of viral genes, and the attraction of co-186 
activator proteins such as p300, TFIID and other RNA polymerase II components 187 
to the promoters (Lieberman & Berk, 1991; 1994) (Fig. 5 and Supplementary Fig. 188 
3). Recent genome-wide analyses have shown that Zta has extensive interactions 189 
across the EBV genome and a specific role in the transcriptional activation of 190 
many viral promoters (Bergbauer et al., 2010; Ramasubramanyan et al., 2012a). 191 
 192 
Li discovered that Zta-mediated repression of CIITA expression occurs in EBV-193 
positive Raji cells, but did not investigate whether other viral genes are required 194 
for the repression (Li et al., 2009). We confirm this and furthermore we show 195 
that the expression of two CIITA-dependent genes are also down regulated. As 196 
Zta expression in EBV positive BL cells, is sufficient to initiate the viral lytic 197 
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replication cycle, many downstream changes in gene expression are expected, 198 
and it is important to determine whether repression requires Zta action alone or 199 
whether it acts in concert with additional viral proteins. Our demonstration that 200 
Zta is able to repress the CIITA promoter in an EBV-negative BL cell line 201 
unequivocally demonstrates that Zta-mediated repression does not require 202 
other viral gene products.  203 
 204 
The relevance of two forms of post-translational modification of Zta that have 205 
been described as transcriptionally repressive was explored. The involvement of 206 
phosphorylation at S209 by the viral protein kinase BGLF4 (Asai et al., 2009) was 207 
investigated using the phospho-mimetic mutant version of Zta S209D and the 208 
phosphorylation dead mutant version Zta S209A. Covalent addition of SUMO at 209 
K12 (Hagemeier et al., 2010; Murata et al., 2010) was assessed using the non-210 
sumoylatable mutant version Zta K12R. Both of these post-translational 211 
modifications have been described as transcriptionally repressive (Asai et al., 212 
2009; Hagemeier et al., 2010; Murata et al., 2010). As none of these Zta mutants 213 
compromised the ability of Zta to repress the CIITA promoter, we conclude that 214 
neither post-translational modification is likely to be responsible for the 215 
observed repression of the CIITA promoter by Zta. 216 
 217 
Zta also regulates gene expression by disrupting transcriptional activation by 218 
NFB and p53 (Morrison & Kenney, 2004; Zhang et al., 1994). This occurs 219 
through physical interactions between Zta and the p65 component of NFB and 220 
between Zta and p53 protein (Morrison & Kenney, 2004; Zhang et al., 1994). 221 
However, it is unlikely that either NFB or p53 plays a role in Zta-mediated CIITA 222 
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repression, as both require the dimerization region of Zta, which is not necessary 223 
for repression of CIITA. In addition, mutation of the NFB interaction site in the 224 
CIITA promoter does not alter either basal expression or Zta mediated 225 
repression (NB, AJS unpublished data).  It is intriguing that Zta has been shown 226 
previously to modulate expression of a viral promoter (Zp) without the need to 227 
bind directly to DNA (Flemington et al., 1994). 228 
 229 
A previous study suggests that Zta repression of the CIITA promoter is driven 230 
through the interaction of Zta with a single ZRE within the promoter (Li et al., 231 
2009). This is supported by the impact of mutations of the ZRE within the 232 
promoter and by the inability of Zta to repress the CIITA promoter when the 233 
basic region is lost. This study places emphasis on a need of Zta to bind directly 234 
to DNA to effect repression. Our experiments support a different conclusion in 235 
which Zta represses CIITA expression without binding directly to DNA. We 236 
rationalize the need for the basic region of the Zta protein based on a 237 
requirement for the nuclear localization domain, which is contained therein 238 
(Mikaelian et al., 1993). Without entry to the nucleus, Zta would not be able to 239 
repress the CIITA promoter through either direct or indirect DNA binding.  240 
 241 
In summary, we show that Zta mediated repression of the CIITA promoter can 242 
occur without Zta contacting DNA directly, this is supported by the retention of 243 
repression when (i) the ZRE is deleted and (ii) by a version of Zta that is 244 
defective for dimerization and therefore defective for DNA-binding. This 245 
discovery leads us to propose a mechanism to describe gene repression by Zta. 246 
In this model the amino terminal region of Zta is able to impede the function of 247 
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an essential component of the transcriptionally active CIITA promoter, for 248 
example a DNA bound transcription factor or a transcription factor-associated 249 
co-activator, thereby preventing its productive association with RNA Pol II and 250 
its accessory proteins (Fig. 5).  251 
 252 
Materials and Methods 253 
 254 
Plasmid constructs. 255 
The CIITA promoter (-286 to +54) was cloned with a Kpn I restriction enzyme 256 
site included at the 5’ end and a Hind III site at the 3’ end of the sequence. The 257 
promoter was sub-cloned into the pGL3 enhancer plasmid, which contains a 258 
luciferase reporter construct down-stream from a multi-cloning site and which 259 
includes a distal SV40 enhancer (Promega). A 5’ deletion version of the promoter 260 
was generated (-214 to +54); the location of the 5’ end of this promoter is 261 
immediately 3’ from the ZRE. 262 
 263 
The BHLF1, BFLF2 and BLLF3 promoters were cloned with a BamHI restriction 264 
enzyme sites added at the 5’ end and Hind III sites at the 3’ end. The DNA 265 
sequence between co-ordinates 40472 and 40818, 45793 and 44746 and 76186 266 
and 77231 of the EBV genome (Human herpesvirus 4 complete wild type 267 
genome Accession: NC_007605.1) were synthesized for the promoter regions for 268 
the BHLF1, BFLF2 and BLLF3 genes respectively. The promoters were sub-cloned 269 
into the pCpGL plasmid (Klug & Rehli, 2006), which is based on pGL3 basic and 270 
contains a luciferase reporter construct down stream from a multi-cloning site.  271 
 272 
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A plasmid driving the expression of hexa-histidine tagged Zta (His-Zta) (Bailey et 273 
al., 2009) was used to express His-Zta, compared to the vector control pcDNA3 274 
(Invitrogen).  275 
 276 
Expression vectors for His-Zta K12R, His-Zta S209A and His-Zta S209D were 277 
generated by site directed mutagenesis of His-Zta using the primers shown in 278 
Table 3. An expression vector for His Zta-199ter which introduces a termination 279 
codon at the amino acid 199 of the Zta coding sequence and His Zta-TA which 280 
deletes amino acids 1-133 of Zta were generated by gene synthesis (Invitrogen).   281 
 282 
Cell culture 283 
Plasmids were introduced into EBV-positive Raji cells (Pulvertaft, 1965) or EBV-284 
negative Akata cells (Jenkins et al., 2000) by electroporation. 1 x 107 cells in 285 
0.25ml of medium were incubated with 10µg of plasmid DNA and pulsed with 286 
250V at a capacitance of 975F in a Gene Pulser II electroporator (Bio-Rad). 287 
 288 
Luciferase assays 289 
48 hours post-transfection cells were harvested into 250µl of Passive Lysis 290 
Buffer (Promega) and incubated at room temperature for 15 minutes. The lysed 291 
cells were then centrifuged for 10min at 8 krpm and the supernatant was used to 292 
determine luciferase activity. 10l aliquots of each lysate sample were pipetted 293 
into a 96-well white luminescence plate and analyzed using luciferase detection 294 
kit reagents with a Glomax detection system (Promega). A protein concentration 295 
assay was undertaken (Biorad) and promoter activity was expressed as 296 
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luciferase RLU/g protein. Significance of different promoter activity was 297 
assessed using a Student’s paired T-test with 2 tail distribution.  298 
 299 
Protein analysis  300 
Proteins were extracted from cells by boiling in 2X Laemeli sample buffer and 301 
fractionated on Novex protein gels (Invitrogen). Following transfer to 302 
nitrocellulose membranes the blots were incubated with the Zta specific 303 
antibody sc-17503 (Santa Cruz) which recognizes the amino-terminal region of 304 
Zta, or BZ1 which recognizes the basic and dimerization regions of Zta (Young et 305 
al., 1991) or a rabbit polyclonal beta actin antibody (Sigma), followed by 306 
detection with HRP-linked secondary antibodies and ECL (Ramasubramanyan et 307 
al., 2012b).  308 
 309 
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 488 
Figure legends 489 
Figure 1. Repression of CIITA promoter by Zta is specific. 490 
The CIITA (-286 to +54)  (a), BHLF1 (b), BFLF2 (c) and BLLF3 (d) promoter-491 
luciferase plasmids and the indicated expression vectors were introduced cells 492 
by electroporation, 48 hours later cells were harvested and the luciferase activity 493 
determined.  a-d. Promoter activity in Raji cells relative to the maximal activity of 494 
CIITA promoter (transfected with control plasmid) with the standard deviation 495 
from six assays (three replicate samples from each of two separate experiments). 496 
For comparisons +/- Zta  ** represents p of significant difference <0.01; * 497 
represents p of significant difference <0.05. The expression of His-Zta and 498 
endogenous protein were analyzed by western blot of proteins from the 499 
transfected cells. 500 
 501 
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Figure 2. Repression of CIITA promoter by Zta is independent of other viral 502 
proteins. 503 
The CIITA (-286 to +54) promoter-luciferase plasmid and the indicated 504 
expression vectors were introduced into an EBV-negative sub-clone of the Akata 505 
BL cells (AK31) by electroporation, 48 hours later cells were harvested and the 506 
luciferase activity determined. Promoter activity is expressed relative to the 507 
maximal activity of CIITA promoter (transfected with control plasmid) with the 508 
standard deviation from six assays (three replicate samples from each of two 509 
separate experiments). For comparisons +/- Zta  ** represents p of significant 510 
difference <0.01;. The expression of His-Zta and endogenous protein were 511 
analyzed by western blot of proteins from the transfected cells. 512 
  513 
Figure 3. Zta repression of CIITA promoter requires the transactivation domain.  514 
The CIITA promoter-luciferase plasmids (-286 to +54) and either control, His-Zta 515 
or His-Zta mutant expression vectors were introduced into Raji BL cells by 516 
electroporation. 48 hours later cells were harvested and the luciferase activity 517 
and protein concentrations determined. For comparisons +/- Zta  ** represents p 518 
of significant difference <0.01; * represents p of significant difference <0.05.  519 
a. Schematic of the Zta protein and the two mutant versions that were evaluated. 520 
TA is transactivation domain; B is basic DNA contact region; ZIP is dimerization 521 
bZIP domain; CT is the Carboxy terminal region (required for dimerisation and 522 
replication). 523 
b. Promoter activity of -286 to +54 promoter with His-ZtaTA with the standard 524 
deviation from six assays (three replicate samples from each of two separate 525 
experiments), together with a western blot. 526 
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c. Promoter activity of -286 to +54 promoter with His-Zta199ter with the 527 
standard deviation from six assays (three replicate samples from each of two 528 
separate experiments), together with a western blot. 529 
 530 
Figure 4. Zta repression of CIITA promoter occurs without binding to the ZRE. 531 
The CIITA promoter-luciferase plasmids (either -286 to +54 or -214 to +54) and 532 
either control,  His-Zta or His-Zta mutant expression vectors were introduced 533 
into Raji BL cells by electroporation. 48 hours later cells were harvested and the 534 
luciferase activity and protein concentrations determined. For comparisons +/- 535 
Zta  ** represents p of significant difference <0.01; * represents p of significant 536 
difference <0.05.  For both His-Zta and  His-ZtaH199ter, the significance is equal 537 
for each of the different promoters.   538 
a. Schematic of the CIITA mutant promoters used in these experiments. The 539 
location of the ZRE is indicated by a filled box.  540 
b. The CIITA basal promoter activity is shown (open) together with the His-Zta 541 
mediated activity (black), with the standard deviation from six assays (three 542 
replicate samples from each of two separate experiments). Western blot analysis 543 
of protein expression in the transfected cells. 544 
 545 
Figure 5. Proposed model to explain Zta mediated gene repression of the CIITA 546 
promoter.  547 
a. The active CIITA promoter is shown. Basal transcription factors are 548 
represented as white spheres and co-activators by the stippled oval. RNA 549 
polymerase II is represented by the black cloud with transcription indicated by 550 
an arrow. 551 
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b. The ability of a non-DNA binding form of Zta (filled oval) to repress expression 552 
of the CIITA promoter suggests that some repression can occur without direct 553 
DNA contact. The simplest model to account for this has the N-terminal part of 554 
Zta blocking the interaction of the basal transcription machinery.  555 
 556 
Tables 557 
Table 1. Impact of mutation of K12 and S209 on Zta mediated repression 558 
 
His-Zta 
His-Zta 
K12R 
His-Zta 
S209A 
His-Zta 
S209D 
CIITA promoter 
activity 
1.00 1.00 1.00 1.00 
Relative promoter 
activity following his-
Zta expression 
0.16 0.07 0.07 0.04 
Standard deviation 0.15 0.08 0.01 0.00 
 559 
Table 2.  Impact of Zta expression on -286 and -214 CIITA promoters  560 
 Average luciferase 
units CIITA 
(-286/+54) 
Average luciferase 
units CIITA 
(-214/+54) 
control 440050 +/- 7113 472832 +/- 15031 
His-Zta 18448 +/- 464 66785 +/- 1917 
 561 
Table 3. Oligonucleotides used to generate mutations. 562 
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 563 His-Zta 
S209A 
Amino acid 
serine 209 
mutated to 
Alanine 
GGCTGCTGCCAAATCAGCTGAAAATGACAGGCTGC
GCC; 
GGCGCAGCCTGTCATTTTCAGCTGATTTGGCAGCA
GCC 
His-Zta 
S209D 
Amino acid 
serine 209 
mutated to 
Glutamic acid 
GGCTGCTGCCAAATCAGATGAAAATGACAGGCTGC
GCC; 
GGCGCAGCCTGTCATTTTCATCTGATTTGGCAGCA
GCC 
His-Zta K12R 
Amino acid 
lysine 12 
mutated to 
arginine 
CTCGACTTCTGAAGATGTAAGATTTACACCTGACC
CATACC;  
GGTATGGGTCAGGTGTAAATCTTACATCTTCAGAA
GTCGAG 
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Supp	  Figure	  1.	  	  	  CIITA	  downstream	  targets.	  
The	  expression	  of	  targets	  of	  CIITA	  were	  inves5gated	  by	  RNA	  seq	  as	  described	  in	  
Ramasubramanyan	  et	  al	  2015).	  	  
The	  rela5ve	  change	  in	  expression	  following	  Zta	  expression	  in	  Akata	  BL	  cells	  	  was	  
determined	  and	  presented	  (FDR<0.05).	  
The	  red	  line	  indicates	  the	  maximum	  reduc5on	  expected	  as	  only	  70%	  of	  cells	  express	  
Zta.	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Supp	  ﬁgure	  2.	  Interac;on	  of	  Zta	  with	  the	  CIITA	  pomoter	  in	  BL	  cells.	  
The	  interac5on	  of	  Zta	  with	  the	  CIITA	  locus	  was	  undertaken	  by	  ChIP-­‐seq	  	  (as	  described	  
in	  Ramasubramanyan	  et	  al	  2015).	  The	  locus	  is	  shown	  chr16:10,923,269-­‐11,066,626.	  A	  
peak	  of	  binding	  is	  seen	  as	  a	  bar	  spanning	  the	  TSS	  of	  the	  gene	  in	  Akata	  BL	  cells	  
undergoing	  ly5c	  replica5on	  cycle.	  
Zta	  binding	  
	  peaks	  (BL)	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Supp	  Figure	  3.	  Ac;va;on	  of	  BHLF1	  promoter	  depends	  on	  ZREs	  in	  BL	  cells.	  
The	  viral	  BHLF1	  promoter-­‐luciferase	  plasmid	  and	  a	  version	  that	  has	  a	  muta5on	  of	  
each	  ZRE	  within	  the	  promoter	  was	  introduced	  into	  BL	  cells	  by	  electorpora5on	  
together	  with	  a	  his-­‐Zta	  expression	  vector	  or	  control	  plasmid.	  48	  hours	  later	  cells	  were	  
harvested	  and	  the	  luciferase	  ac5vity	  and	  protein	  concentra5ons	  determined.	  	  
A.  Rela5ve	  ac5vity	  of	  promoters	  (log10	  scale).	  
B.  Western	  blot	  showing	  his-­‐Zta	  and	  ac5n	  expression.	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